fda tirzepatide update What is the latest on the Compounded ban FDA SIDE EFFECTS UPDATE: Kidney

Given that retatrutide is not currently licensed in the UK, any access to this compound outside of a clinical trial would be through unlicensed or unregulated channels, carrying both legal implications and significant safety risks

Bremelanotide: New Drug Approved for Treating Hypoactive Sexual Desire Disorder

If your provider prescribed a GLP-1 agonist for you, know that while it can decrease appetite and promote weight loss, your provider may take a comprehensive approach that also includes exercise, diet changes, behavioral modifications, or sometimes even bariatric surgery

Make immune support simple with vitamin C and glutathione from Core Med Science

RNA-seq analysis confirmed its efficacy in restoring gut barrier integrity at the gene expression level

The AMPK pathway plays an essential role in the expression of PPAR (Zhou et al., 2020)